Mirati Therapeutics, Inc. (MRTX) Financial Statements (2024 and earlier)

Company Profile

Business Address 3545 CRAY COURT
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments779,434902,2941,083,8371,200,9921,181,3281,326,474
Cash and cash equivalents129,866241,925235,260298,843265,602304,696
Short-term investments649,568660,369848,577902,149915,7261,021,778
Receivables12,1718,5893,7351,6851,5321,810
Inventory, net of allowances, customer advances and progress billings8,6443,8493,020   
Inventory8,6443,8493,020   
Prepaid expense15,14119,24515,20715,70010,93511,797
Other undisclosed current assets3,5275,3733,1627,4079,1313,036
Total current assets:818,917939,3501,108,9611,225,7841,202,9261,343,117
Noncurrent Assets
Operating lease, right-of-use asset35,43135,78336,12236,46036,82337,229
Property, plant and equipment16,86717,18517,54017,90017,16317,177
Long-term investments and receivables4,5653,3533,4651,8822,6353,141
Long-term investments4,5653,3533,4651,8822,6353,141
Intangible assets, net (including goodwill)14,39714,65514,914   
Intangible assets, net (excluding goodwill)14,39714,65514,914   
Other noncurrent assets24,86623,43521,64521,05820,24320,635
Total noncurrent assets:96,12694,41193,68677,30076,86478,182
TOTAL ASSETS:915,0431,033,7611,202,6471,303,0841,279,7901,421,299
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities107,483102,28044,334136,097116,92795,633
Employee-related liabilities28,56322,049
Accrued liabilities107,483102,28044,334107,53494,87895,633
Other undisclosed current liabilities32,50722,320115,114(9,111)2,22027,938
Total current liabilities:139,990124,600159,448126,986119,147123,571
Noncurrent Liabilities
Long-term debt and lease obligation:    44,09345,82345,829
Liabilities, other than long-term debt46,10246,53146,6832,9512,8162,617
Other liabilities3,3803,3043,0222,9512,8162,617
Operating lease, liability42,72243,22743,66144,09345,82345,829
Total noncurrent liabilities:46,10246,53146,68347,04448,63948,446
Total liabilities:186,092171,131206,131174,030167,786172,017
Equity
Equity, attributable to parent728,951862,630996,5161,129,0541,112,0041,249,282
Common stock585858585656
Additional paid in capital3,544,9963,501,7543,453,0663,385,5393,185,4443,145,368
Accumulated other comprehensive income (loss)(1,715)(1,707)(3,719)(6,129)3,3574,266
Accumulated deficit(2,814,388)(2,637,475)(2,452,889)(2,250,414)(2,076,853)(1,900,408)
Total equity:728,951862,630996,5161,129,0541,112,0041,249,282
TOTAL LIABILITIES AND EQUITY:915,0431,033,7611,202,6471,303,0841,279,7901,421,299

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues13,6907,1679345,4315,362709
Gross profit:13,6907,1679345,4315,362709
Operating expenses(200,960)(200,990)(212,657)(191,874)(182,567)(184,927)
Operating loss:(187,270)(193,823)(211,723)(186,443)(177,205)(184,218)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
10,3579,2379,50213,136760(4,168)
Loss from continuing operations before income taxes:(176,913)(184,586)(202,221)(173,307)(176,445)(188,386)
Income tax expense   (254)(254)  
Loss from continuing operations:(176,913)(184,586)(202,475)(173,561)(176,445)(188,386)
Loss before gain (loss) on sale of properties:(173,561)(176,445)(188,386)
Net loss available to common stockholders, diluted:(176,913)(184,586)(202,475)(173,561)(176,445)(188,386)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(176,913)(184,586)(202,475)(173,561)(176,445)(188,386)
Comprehensive loss:(176,913)(184,586)(202,475)(173,561)(176,445)(188,386)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(8)2,0122,410(9,486)(909)(4,802)
Comprehensive loss, net of tax, attributable to parent:(176,921)(182,574)(200,065)(183,047)(177,354)(193,188)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: